HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

888.924

+19.0212.19%

Number of Gainers:7

Number of Losers:4

Number of Flat:2

PE:- -

High:889.473

Open:868.780

Low:861.334

Close:869.902

Volume:11.50M

Turnover:114.18M

Market Cap:147.77B

Float Cap:109.04B

Loading ...

Sinopharm Group Stock Rallies 0.9% in Hong Kong

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Sisram Medical Declares HKD 0.095 Final Dividend for Fy2025

Sinopharm Group Stock Advances 1.5% in Hong Kong

Angelalign Shares Rally Nearly 5% on Overseas Profitability and Strong Sales Momentum

Lai Fung Announces Public Float at 14.76% as of Sept 3

CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)

CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis

China Medical System Holdings Limited Nda for Additional Indication Ad for Ruxolitinib Phosphate Cream Lumirix Approved in China

THOMSON REUTERS

China Medical System Wins China Approval for Ruxolitinib Cream in Atopic Dermatitis

China Medical System Holdings - Dermavon Receives Nmpa Approval for Lumirix Nda for Atopic Dermatitis on Sept 2, 2026

THOMSON REUTERS

Lai Fung Holdings Public Float Falls Short of Listing Threshold

Lai Fung Holdings Public Float Stays Below HKEX 25% Minimum at 14.76%

Lai Fung - Public Float at 14.76% as of Sept 3, 2026, Below Required 25%

THOMSON REUTERS

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China

THOMSON REUTERS

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK1593/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":888.9237,"timestamp":1789352894818,"preClose":869.9022,"halted":0,"volume":11501303,"delay":0,"changeRate":0.021866,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":19.021484,"latestTime":"09-14 10:28:15","open":868.77954,"high":889.47296,"low":861.3339,"amount":114184786,"amplitude":0.032347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789358400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":1.117247,"peRate":10.209827,"turnoverRate":0.000577,"increases":7,"decrements":4,"flats":2,"marketCap":147770515032,"floatMarketCap":109037686296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":889.47296,"amplitude":0.032347,"preClose":869.9022,"low":861.3339,"pbRate":"1.117247","latestPrice":888.9237,"volume":11501303,"delay":0,"open":868.77954,"prevYearClose":1094.978,"prevWeekClose":869.902,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":913.448,"twentyDayClose":958.802,"sixtyDayClose":844.161,"secType":"PLATE","market":"HK","turnoverRate":0.000577,"peRate":10.209827,"marketCap":147770515032,"floatMarketCap":109037686296,"timestamp":1789352894818,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":7,"down":4,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665900313","title":"Sinopharm Group Stock Rallies 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665900313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665900313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 15.83 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 29% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 7.1%.Trading volume totaled 4.5 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0175","BK0187","BK0096","SHTDY","LU0640798160.USD","BK1593","LU1115378108.SGD","BK0028","BK0239","BK0196","02196","BK1191","BK1500","BK1515","01099","BK4175","BK1197","BK0060","BK0183","600196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992823","title":"Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992823","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992823?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:05","pubTimestamp":1788757530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical , along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0196","BK0239","BK1593","BK0188","BK0096","BK0187","02196","BK0183","BK0060","BK0012","600196","BK0175","BK1515","BK0028","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06978","MEDX","BK1593","BK4588","CHAT","AIPO","BK1161","BK1515","VXUS","BK1574","BK4585","ARTY","02228","VTHR","QTOC","BK1617","159992","IBBQ","LNGR","03696","AGIX","BK1191","02196","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364504","title":"Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364504","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364504?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:34","pubTimestamp":1788690846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nL6N44Y02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK0187","BK0239","BK0183","02196","600196","BK0096","BK0175","BK0028","BK1191","BK0188","BK1593","BK0060","BK0196","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120592433","title":"Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1120592433","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120592433?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:04","pubTimestamp":1788685454,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that its controlling subsidiary, Fosun Pharma Singapore, executed a share sale of Gland Pharma shares on September 4, 2026...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","02196","BK0239","BK1191","BK0175","BK0188","BK0096","BK1515","BK0183","BK1593","BK0012","BK0060","BK0028","BK0187","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339079","title":"Sisram Medical Declares HKD 0.095 Final Dividend for Fy2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339079","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339079?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:53","pubTimestamp":1788522800,"startTime":"0","endTime":"0","summary":"Sisram Medical declares HKD 0.095 final dividend for FY2025Sisram Medical declared a final dividend of HKD 0.095 per share for the year ended Dec. 31, 2025.Shares trade ex-dividend on Aug. 26, 2026.Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8TGg3k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","BK1585","BK1100","01696","BK1593","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0175","BK0187","BK0096","SHTDY","LU0640798160.USD","BK1593","LU1115378108.SGD","BK0028","BK0239","BK0196","02196","BK1191","BK1500","BK1515","01099","BK4175","BK1197","BK0060","BK0183","600196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176570628","title":"Angelalign Shares Rally Nearly 5% on Overseas Profitability and Strong Sales Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1176570628","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176570628?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:43","pubTimestamp":1788504193,"startTime":"0","endTime":"0","summary":"Shares of Angelalign (06699) advanced nearly 5% during Hong Kong trading on Wednesday, last up 3.62% at HK$98.70 with turnover reaching HK$60.63 million.The surge follows the company's 2026 interim...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775SV38.USD","LU1548497426.USD","LU0158827781.USD","BK1593","LU0225283273.USD","LU0795875086.SGD","LU0006306889.USD","BK4127","LU1244550494.USD","LU2347655156.SGD","LU1668664300.SGD","LU1720051108.HKD","LU2111349929.HKD","LU2264538146.SGD","BK4581","LU0528227936.USD","BK4588","LU0106261372.USD","LU2028103732.USD","KBWB","VXUS","BK4504","BK4585","LU2357305700.SGD","LU1989772840.SGD","IE00BZ1G4Q59.USD","LU0320765646.SGD","LU0971096721.USD","LU0053666078.USD","BK4516","LU1162221912.USD","BK1587","IE00BKVL7J92.USD","LU1732800096.USD","LU0557290698.USD","LU2023251221.USD","MS","LU0158827948.USD","LU1074936037.SGD","LU0882574139.USD","LU1244550577.SGD","LU1720051017.SGD","LU0795875169.SGD","LU2089284900.SGD","BK1583","BK4534","LU0912757837.SGD","LU0098860793.USD","LU0314104364.USD","LU1732799900.SGD","LU1989772923.USD","LU2133065610.SGD","LU1988902786.USD","IAI","06699","LU0390134368.USD","LU2271345857.HKD","IE00B3S45H60.SGD","LU1244550221.USD","LU2487616109.SGD","KCAI","LU1064131342.USD","LU1791710400.SGD","BK1100","LU0210528500.USD","LU1791710582.SGD","LU0267386448.USD","LU0234570918.USD","LU1363072403.SGD","LU2089283258.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664354803","title":"Lai Fung Announces Public Float at 14.76% as of Sept 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2664354803","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664354803?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:38","pubTimestamp":1788449902,"startTime":"0","endTime":"0","summary":"BRIEF-Lai Fung Announces Public Float At 14.76% As Of Sept 3Sept 3 (Reuters)-Lai Fung Holdings Ltd1125.HK:PUBLIC FLOAT AT 14.76% AS OF SEPT 3, 2026, BELOW REQUIRED 25%Further company coverage:1125.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01125","BK1240","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087717","title":"CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087717","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087717?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:08","pubTimestamp":1788437280,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355884/0/en/cms-867-hk-8a8-sg-innovative-drug-lumirix-approved-in-china-for-additional-indication-of-atopic-dermatitis-ad.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","SG9999015945.SGD","LU2488822045.USD","LU1223083913.SGD","LU1223082196.USD","IE00BMCWC346.EUR","BK1593","BK4017","BK4132","XME","SGDM","SG9999015986.USD","BK4200","SG9999015952.SGD","CDE","SG9999015978.USD","IE00BYV24P56.USD","BK1191","GDXJ","SG9999004220.SGD","IE00BVYPNQ40.USD","AD","TCS","LU1223082519.USD","00867","IE00BGHQDM52.EUR","SIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176808711","title":"CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1176808711","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176808711?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429862,"startTime":"0","endTime":"0","summary":"CMS (00867) has announced that its subsidiary, Demei Pharma, obtained approval from China's National Medical Products Administration (NMPA) on September 2, 2026, for the New Drug Application (NDA) of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK4132","BK1574","IE00BYV24P56.USD","SG9999004220.SGD","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","BK1191","SG9999015978.USD","SG9999015986.USD","IPOS","BK1161","LNGR","MEDX","SG9999015945.SGD","IE00BGHQDM52.EUR","LU2488822045.USD","IE00BMCWC346.EUR","06978","SG9999015952.SGD","IBBQ","159992","AD","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664310875","title":"China Medical System Holdings Limited Nda for Additional Indication Ad for Ruxolitinib Phosphate Cream Lumirix Approved in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664310875","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664310875?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:03","pubTimestamp":1788429783,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUE6SFBSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00867","BK1593","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999015986.USD","SG9999004220.SGD","IE00BVYPNP33.GBP","SG9999015978.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664732438","title":"China Medical System Wins China Approval for Ruxolitinib Cream in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2664732438","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664732438?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:55","pubTimestamp":1788429343,"startTime":"0","endTime":"0","summary":"China Medical System wins China approval for ruxolitinib cream in atopic dermatitisChina Medical System unit Dermatology Medical won NMPA clearance for ruxolitinib phosphate cream Bairutuo to treat mi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL4Z4zrb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","BK1593","IE00BGHQDM52.EUR","LU2488822045.USD","SG9999004220.SGD","IE00BVYPNP33.GBP","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","SG9999015952.SGD","IE00BYV24P56.USD","00867","SG9999015978.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664732178","title":"China Medical System Holdings - Dermavon Receives Nmpa Approval for Lumirix Nda for Atopic Dermatitis on Sept 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664732178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664732178?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:55","pubTimestamp":1788429329,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U189:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015978.USD","LU2488822045.USD","00867","IE00BVYPNQ40.USD","SG9999015986.USD","IE00BVYPNP33.GBP","SG9999004220.SGD","BK1191","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158812292","title":"Lai Fung Holdings Public Float Falls Short of Listing Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=1158812292","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158812292?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:44","pubTimestamp":1788428652,"startTime":"0","endTime":"0","summary":"LAI FUNG HOLD (01125) has announced that as of the date of this notice, its public float stands at 14.76%.This figure remains below the 25% minimum threshold of total issued share capital required to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01125","BK1593","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873581","title":"Lai Fung Holdings Public Float Stays Below HKEX 25% Minimum at 14.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873581?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:41","pubTimestamp":1788428485,"startTime":"0","endTime":"0","summary":"Lai Fung Holdings public float stays below HKEX 25% minimum at 14.76%Lai Fung’s public float stood at 14.76%, below the 25% minimum required under Hong Kong listing rules.The shortfall keeps the compa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8F8649:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","00191","01125","BK1229","BK1593","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873378","title":"Lai Fung - Public Float at 14.76% as of Sept 3, 2026, Below Required 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873378?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:41","pubTimestamp":1788428471,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","01125","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878952","title":"Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878952?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:20","pubTimestamp":1788427213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","BK0028","600196","BK0183","BK0196","02196","BK1593","BK0060","BK0175","BK0239","BK0188","BK0012","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878574","title":"Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878574?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:18","pubTimestamp":1788427127,"startTime":"0","endTime":"0","summary":"Sihuan Pharma affiliate Xuanzhu Biopharm grants Innobic exclusive Thailand commercialization rights for Bireociclib tabletsSihuan Pharmaceutical’s non-wholly owned unit Xuanzhu Biopharm granted exclus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8K9jwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1600","02575","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168391109","title":"Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1168391109","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168391109?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:26","pubTimestamp":1788423987,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its majority-owned subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK1191","BK0012","BK0175","BK1593","600196","BK0028","BK0188","BK0239","BK0060","02196","BK1515","BK0096","BK0187","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}